Markus K. Schuler

Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study

Viktor Grünwald, Annika Karch, Markus K. Schuler et al. · Journal of Clinical Oncology · 2020 · 91 citations

Medicine, Oncology, Pharmacotherapy +17

The ANIMAL algorithm animation tool

Guido Rößling, Markus K. Schuler, Bernd Freisleben · 2000 · 75 citations · Full text

Computing, Teaching, Visualization +14

Burden of soft-tissue and bone sarcoma in routine care

Freya Trautmann, Markus K. Schuler, Jochen Schmitt · Cancer Epidemiology · 2015 · 60 citations

Medicine, Oncology, Surgery +14

The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of a Nationwide Observational Study (PROSa)

Martin Eichler, Leopold Hentschel, Stephan Richter et al. · Cancers · 2020 · 57 citations · Full text

Nursing, Oncology, Cancer Survivorship Care +16

Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment—A Randomized Controlled Trial

Markus K. Schuler, Leopold Hentschel, Wadim Kisel et al. · Journal of Pain and Symptom Management · 2016 · 56 citations · Full text

Medicine, Oncology, Rehabilitation Medicine +14